| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0042-6822(03)00167-3 |
| P698 | PubMed publication ID | 12781713 |
| P50 | author | Eric Delaporte | Q33106021 |
| Florian Liegeois | Q42341151 | ||
| Eitel Mpoudi-Ngolé | Q52379388 | ||
| Christian Laurent | Q73467544 | ||
| Martine Peeters | Q90016216 | ||
| Anke Bourgeois | Q114410272 | ||
| Rose Mougnutou | Q114410273 | ||
| Léopold Zekeng | Q114410274 | ||
| Christelle Butel | Q115566183 | ||
| Laurence Vergne | Q117267162 | ||
| Josephine Mbuagbaw | Q117267184 | ||
| P2860 | cites work | Genotypic and phenotypic characterization of HIV-1 patients with primary infection | Q22242245 |
| Mt-2 Cell Tropism Of Human Immunodeficiency Virus Type 1 Isolates As A Marker For Response To Treatment And Development Of Drug Resistance | Q22242877 | ||
| CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
| Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda | Q28217042 | ||
| Reduced rate of disease development after HIV-2 infection as compared to HIV-1 | Q28237927 | ||
| Human immunodeficiency virus type 1 subtypes differ in disease progression | Q28290683 | ||
| Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. | Q28379463 | ||
| Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. | Q30322838 | ||
| Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. | Q30326923 | ||
| Slower heterosexual spread of HIV-2 than HIV-1. | Q30419674 | ||
| Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon. | Q33817736 | ||
| Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features | Q33951471 | ||
| Geographical distribution of HIV-1 group O viruses in Africa | Q34420359 | ||
| Estimation of evolutionary distances between homologous nucleotide sequences | Q35309976 | ||
| Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate | Q36629169 | ||
| Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule | Q36697652 | ||
| Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates | Q36827410 | ||
| HIV-1 genetic variability in Cameroon | Q39066690 | ||
| Differential diagnosis of HIV type 1 group O and M infection by polymerase chain reaction and PstI restriction analysis of the pol gene fragment | Q39066697 | ||
| An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. | Q39550685 | ||
| Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon. | Q40637101 | ||
| Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks | Q40782000 | ||
| Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients | Q40953782 | ||
| Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses | Q40973833 | ||
| Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. | Q41058835 | ||
| Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. | Q41557849 | ||
| HIV-1 group O infection in Cameroon, 1986 to 1998. | Q41840717 | ||
| The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon | Q42654318 | ||
| Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon | Q42668215 | ||
| Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries | Q43599504 | ||
| What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. | Q44290280 | ||
| No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a f | Q45731204 | ||
| Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon | Q45740892 | ||
| An unusual HIV type 1 env sequence embedded in a mosaic virus from Cameroon: identification of a new env clade. European Network on the study of in utero transmission of HIV-1. | Q45746006 | ||
| Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. | Q45753861 | ||
| HIV-1 group N among HIV-1-seropositive individuals in Cameroon. | Q46200964 | ||
| Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes | Q46377003 | ||
| Impact of HIV type 1 subtype variation on viral RNA quantitation | Q46629279 | ||
| HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients | Q46794671 | ||
| Triple HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient | Q46917106 | ||
| Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence | Q47867032 | ||
| HIV type 1 diversity and the reliability of the heteroduplex mobility assay | Q48035941 | ||
| Characterization of HIV Type 1 from Romanian Children: Lack of Correlation between V3 Loop Amino Acid Sequence and Syncytium Formation in MT-2 Cells | Q48074209 | ||
| HIV-1 nomenclature proposal | Q48750867 | ||
| Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. | Q52843609 | ||
| HIV-1 subtypes and male-to-female transmission in Thailand | Q64135029 | ||
| Lack of correlation between V3 amino acid sequence and syncytium-inducing capacity of some HIV type 1 isolates | Q71515617 | ||
| Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions | Q71908038 | ||
| Diagnosis of HIV-1 group O infection by polymerase chain reaction | Q71926019 | ||
| Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns | Q77536576 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cameroon | Q1009 |
| phenotype | Q104053 | ||
| P304 | page(s) | 254-266 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage | |
| P478 | volume | 310 |
| Q36834771 | A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants |
| Q35807096 | A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection |
| Q30378660 | A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies |
| Q35817460 | Antiretroviral drug resistance and routine therapy, Cameroon |
| Q39808350 | Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures. |
| Q36084257 | CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon |
| Q37333651 | Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. |
| Q35895944 | Commercial logging and HIV epidemic, rural Equatorial Africa |
| Q27664241 | Conformational Adaptation of Asian Macaque TRIMCyp Directs Lineage Specific Antiviral Activity |
| Q42630740 | Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial |
| Q40546379 | Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon |
| Q33793066 | Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa |
| Q52840232 | Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. |
| Q37256389 | Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism. |
| Q34473354 | Genotypic prediction of tropism of highly diverse HIV-1 strains from Cameroon |
| Q34213839 | HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea |
| Q36376394 | HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges |
| Q30352511 | HIV-1 subtype C in vitro growth and coreceptor utilization. |
| Q30394967 | High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo |
| Q33736978 | High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses |
| Q22241756 | Identifying HIV-1 dual infections |
| Q33515282 | Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon |
| Q30407564 | Lack of adaptation to human tetherin in HIV-1 group O and P. |
| Q30976528 | Linkage analysis of ordinal traits for pedigree data |
| Q36423642 | Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. |
| Q37586704 | Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon |
| Q92233898 | Near full genome characterization of HIV-1 unique recombinant forms in Cameroon reveals dominant CRF02_AG and F2 recombination patterns |
| Q30432689 | Non-M variants of human immunodeficiency virus type 1. |
| Q36246353 | Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated western lowland gorillas in Cameroon |
| Q39919619 | Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms |
| Q37099857 | Origin and biology of simian immunodeficiency virus in wild-living western gorillas |
| Q26849291 | Origin and diversity of human retroviruses |
| Q36510410 | Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals |
| Q30353669 | Phylodynamics of the HIV-1 epidemic in Cuba. |
| Q41825435 | Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide. |
| Q36667567 | Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains |
| Q35202569 | Statistical Analysis in Genetic Studies of Mental Illnesses |
| Q30377499 | The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon. |
| Q38134898 | The origin and molecular epidemiology of HIV. |
| Q34885559 | The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness |
| Q33884059 | The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates |
| Q33856274 | Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting |
| Q36581795 | Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon |
Search more.